Pharmacological studies of 3'-(4-morpholinyl)-3'-deaminodaunorubicin in human colon carcinoma cells in vitro.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents; D002470:Cell Survival; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004261:DNA Replication / Q000187:drug effects; D003630:Daunorubicin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D012313:RNA / Q000096:biosynthesis; D013997:Time Factors
D000970:Antineoplastic Agents; D012313:RNA; C034844:3'-(4-morpholinyl)-3'-deaminodaunorubicin; D004317:Doxorubicin; D003630:Daunorubicin